Description
Antiviral 99% Purity CAS 142217-69-4 Entercavir Medical Raw Material
Description
| Product Name: | Entecavir | Other Name: | Etv |
|---|---|---|---|
| CAS No: | 142217-69-4 | Purity: | 99% Min |
| Shelf Life: | 2 Years | Application: | Medication |
| Sample: | Available | Storage: | Cool And Dry Place |
| Appearance: | White Crystalline Powder | Delivery Time: | Prompt Delivery |
| High Light: |
CAS 142217-69-4 Medical Raw Material, Entercavir Medical Raw Material, Antiviral Entercavir |
||
Medical Raw Material Antiviral 99% Purity CAS 142217-69-4 Entercavir
Product Introduction
Name: Entecavir
English synonyms: etv
Molecular formula: C12H15N5O3
Molecular weight: 277.28
EINECS Number: 604-279-5
Product Description
Melting point: 249-252°C
Boiling point: 661.4±65.0°C(Predicted)
Density: 1.81±0.1g/cm3(Predicted)
Storage conditions: -20°C
Form: powder
Acidity coefficient (pKa): 14.22±0.60 (Predicted)
Color: white to beige
Optical activity: [α]/D+25to+40°,c=0.2inH2O
Product Function
Entecavir is a new-generation guanine nucleoside analog oral drug used to treat hepatitis B virus infection. It is mainly used to treat chronic type B with active viral replication and continuous increase in serum transaminase in adults, or active liver histology. Hepatitis is currently the fastest and strongest nucleoside analogue that reduces the virus and has the lowest mutation rate.
The data shows that different chronic hepatitis B patients, including patients with initial nucleoside treatment, nucleoside treatment, and liver cirrhosis, can quickly control their condition through treatment with Entecavir tablets, and easily reach the realistic end of treatment, that is, the hepatitis B virus is undetectable; through persistence For treatment, a considerable number of patients can reach the satisfactory endpoint of treatment, that is, e-antigen seroconversion, and some patients can even reach the ideal endpoint of treatment, that is, the surface antigen becomes negative.
